世界最新医学信息文摘(电子版)
世界最新醫學信息文摘(電子版)
세계최신의학신식문적(전자판)
World Latest Medicine Information
2013年
15期
29-30
,共2页
石太平%代斯日古楞%Gu Leng
石太平%代斯日古楞%Gu Leng
석태평%대사일고릉%Gu Leng
慢性前列腺炎%良性前列腺增生症%临床研究
慢性前列腺炎%良性前列腺增生癥%臨床研究
만성전렬선염%량성전렬선증생증%림상연구
chronic prostatitis%Benign prostatic hyperplasia. Clinical research
目的:对良性前列腺增生症与慢性前列腺炎之间的关系进行研究和分析,同时探讨良性前列腺增生症(BPH)合并慢性前列腺炎(CP)临床特点。方法对我院收治的192例良性BPH患者的临床资料进行回顾性分析和总结。结果192例前列腺增生患者中,发生前列腺增生合并慢性前列腺炎患者132例,占68.8%;单纯前列腺增生患者60例,占31.2%。前列腺I、II、III度增生患者发生CP的几率分别为52.6%(101/192)、64.6%(124/192)、89.6%(172/192)。前列腺III度增生与I、II度发生CP率相比,χ2分别为8.725、5.318,P均<0.05。结论前列腺炎症在BPH疾病的发展过程中起到了一定的助推作用,并且会加重病情的发展。当两种疾病合并,加之患者年龄因素影响,常会伴有其他疾病,因此需要对其进行积极地治疗和预防。
目的:對良性前列腺增生癥與慢性前列腺炎之間的關繫進行研究和分析,同時探討良性前列腺增生癥(BPH)閤併慢性前列腺炎(CP)臨床特點。方法對我院收治的192例良性BPH患者的臨床資料進行迴顧性分析和總結。結果192例前列腺增生患者中,髮生前列腺增生閤併慢性前列腺炎患者132例,佔68.8%;單純前列腺增生患者60例,佔31.2%。前列腺I、II、III度增生患者髮生CP的幾率分彆為52.6%(101/192)、64.6%(124/192)、89.6%(172/192)。前列腺III度增生與I、II度髮生CP率相比,χ2分彆為8.725、5.318,P均<0.05。結論前列腺炎癥在BPH疾病的髮展過程中起到瞭一定的助推作用,併且會加重病情的髮展。噹兩種疾病閤併,加之患者年齡因素影響,常會伴有其他疾病,因此需要對其進行積極地治療和預防。
목적:대량성전렬선증생증여만성전렬선염지간적관계진행연구화분석,동시탐토량성전렬선증생증(BPH)합병만성전렬선염(CP)림상특점。방법대아원수치적192례량성BPH환자적림상자료진행회고성분석화총결。결과192례전렬선증생환자중,발생전렬선증생합병만성전렬선염환자132례,점68.8%;단순전렬선증생환자60례,점31.2%。전렬선I、II、III도증생환자발생CP적궤솔분별위52.6%(101/192)、64.6%(124/192)、89.6%(172/192)。전렬선III도증생여I、II도발생CP솔상비,χ2분별위8.725、5.318,P균<0.05。결론전렬선염증재BPH질병적발전과정중기도료일정적조추작용,병차회가중병정적발전。당량충질병합병,가지환자년령인소영향,상회반유기타질병,인차수요대기진행적겁지치료화예방。
Objective to benign prostatic hyperplasia with research and analysis on the relationship between chronic prostatitis, at the same time explore benign prostatic hyperplasia (BPH) combined the clinical characteristics of chronic prostatitis (CP). Methods the records of 192 patients with benign BPH institutes to me the clinical data were retrospectively analyzed and summarized. The Results of 192 cases of patients with hyperplasia of prostate, in which the prostate hyperplasia combined 132 cases of patients with chronic prostatitis, accounted for 68.8%;Pure 60 patients with prostatic hyperplasia, accounted for 31.2%. Patients with hyperplasia of prostate I, II, III, the chance of CP were 52.6%(101/192), 64.6%(124/192), 89.6%(172/192). Hyperplasia of prostate III degree compared with degree in CP I, II, X2 were 8.725, 8.725, P<0.05). Conclusion prostatitis BPH disease progression in the process played a role in boosting and will aggravate the disease progresses. When the two diseases combined, combined with patient age factors, often associated with other diseases, so it needs to be active in treatment and prevention.